Attention, all clinical researchers If you have ever struggled to explain your research findings to non-experts, the European Union (EU) is here to help. Since 2022, for all clinical trials run with medicines or innovative medical devices the results need to be presented in a lay summary, this means a simplified explanation of the research findings, written in language that is accessible to the general public.

This new Clinical Trial Regulation is a game-changer for clinical researchers because you need now to make your work more transparent and understandable to a wider audience. Not only does it help you communicate your research to non-experts, but it will also increase public engagement with science and promote a more inclusive scientific community. Writing your lay summary is a small step that could make a big difference in advancing the understanding and appreciation of science. Last, but not least, it is a moral duty for scientists to share the findings of their work with the people who participated in studies.

This website will provide you with the guidance and resources you need to develop effective, patient-centred lay summaries that meet regulatory requirements and contribute to a more transparent and patient-focused approach to clinical research.